Cargando…
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
Background: The large individual variability in response to drugs for smoking cessation suggests that specific treatments can be more effective in particular subgroups of smokers. In the context of personalized medicine, the main aim of the present study was to evaluate whether the CHRNA4 and CHRNB2...
Autores principales: | Rocha Santos, Juliana, Tomaz, Paulo R. X., Issa, Jaqueline S., Abe, Tânia O., Krieger, José E., Pereira, Alexandre C., Santos, Paulo C. J. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343187/ https://www.ncbi.nlm.nih.gov/pubmed/25774163 http://dx.doi.org/10.3389/fgene.2015.00046 |
Ejemplares similares
-
Cue restricted smoking increases quit rates with varenicline
por: Scholz, Jaqueline R., et al.
Publicado: (2021) -
Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment
por: Santos, Juliana Rocha, et al.
Publicado: (2020) -
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022) -
The association between the nicotinic acetylcholine receptor α4 subunit gene (CHRNA4) rs1044396 and Internet gaming disorder in Korean male adults
por: Jeong, Jo-Eun, et al.
Publicado: (2017) -
Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2018)